Gland Pharma Q4 Results

  • BSE: 543245
  • NSE: GLAND
  • ISIN: INE068V01023
  • Sector: Biotechnology & Drugs
BSE
1,78528.45 (1.62%)
Volume4.99 K
Updated: Mon 25 Nov, 2024 | 15:29:46
NSE
1,773.9518.90 (1.08%)
Volume1.73 L
Updated: Mon 25 Nov, 2024 | 15:40:43
Today: 1,755.70
1,793.75
52-Wk: 1,590.00
2,220.95

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Gland Pharma Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 1,537.45938.29-%785.01-%
    Selling/ General/ Admin Expenses Total 409.49130.35-%132.33-%
    Depreciation/ Amortization 92.6137.61-%37.54-%
    Other Operating Expenses Total 169.9391.30-%119.42-%
    Total Operating Expense 1,271.41686.33-%710.60-%
    Operating Income 266.04251.96-%74.41-%
    Net Income Before Taxes 298.23310.85-%111.15-%
    Net Income 192.42231.95-%78.68-%
    Diluted Normalized EPS 11.6814.08-%7.19-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts